This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Fibroblast growth factor receptor 3D receptor
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 8: | Line 8: | ||
*''FGFR1 tyrosine kinase domain (TKD) residues 458-765'' | *''FGFR1 tyrosine kinase domain (TKD) residues 458-765'' | ||
| - | **[[4uwy | + | **[[4uwy]] – hFGFR1 TKD - human<br /> |
**[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br /> | **[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br /> | ||
**[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[5o4a]], [[6mzw]], [[6c1o]], [[6mzq]], [[6mzw]] – hFGFR1 TKD + inhibitor <br /> | **[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[5o4a]], [[6mzw]], [[6c1o]], [[6mzq]], [[6mzw]] – hFGFR1 TKD + inhibitor <br /> | ||
| - | **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1 | + | **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1]], [[6c18]], [[6c19]], [[6c1b]], [[6c1c]], [[5z0s]], [[6agx]], [[6itj]], [[6nvl]], [[6p68]], [[6p69]], [[7ozb]], [[7ozd]], [[7ozf]], [[7ozy]], [[7wcw]] – hFGFR1 TKD (mutant) + inhibitor <br /> |
| - | **[[5zv2]] – hFGFR1 TKD (mutant) + anti-cancer drug<br /> | + | **[[5zv2]], [[7wcl]] – hFGFR1 TKD (mutant) + anti-cancer drug<br /> |
**[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | **[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | ||
**[[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br /> | **[[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br /> | ||
| Line 37: | Line 37: | ||
*FGFR2 | *FGFR2 | ||
| - | *''FGFR2 tyrosine kinase domain'' | + | *''FGFR2 tyrosine kinase domain 413-821'' |
**[[1gjo]], [[1oec]], [[2psq]] – hFGFR2 TKD <br /> | **[[1gjo]], [[1oec]], [[2psq]] – hFGFR2 TKD <br /> | ||
| Line 44: | Line 44: | ||
**[[3b2t]] – hFGFR2 TKD (mutant) + adenosine derivative<br /> | **[[3b2t]] – hFGFR2 TKD (mutant) + adenosine derivative<br /> | ||
**[[2pvf]] – hFGFR2 TKD with PTR + ACP + substrate peptide<br /> | **[[2pvf]] – hFGFR2 TKD with PTR + ACP + substrate peptide<br /> | ||
| - | **[[3cly]] – hFGFR2 TKD (mutant) with PTR + ACP <br /> | + | **[[3cly]], [[6v6q]] – hFGFR2 TKD (mutant) with PTR + ACP <br /> |
**[[5eg3]] – hFGFR2 TKD (mutant) with PTR + ACP + phospholipase C γ<br /> | **[[5eg3]] – hFGFR2 TKD (mutant) with PTR + ACP + phospholipase C γ<br /> | ||
| - | **[[3ri1]], [[6lvk]], [[6lvl]] – hFGFR2 TKD + inhibitor<br /> | + | **[[3ri1]], [[6lvk]], [[6lvl]], [[8e1x]] – hFGFR2 TKD + inhibitor<br /> |
| + | **[[7kia]], [[7kie]] – hFGFR2 TKD (mutant) + inhibitor<br /> | ||
*''FGFR2 ligand-binding domain'' | *''FGFR2 ligand-binding domain'' | ||
| - | **[[3dar]], [[3caf]], [[3euu]] – hFGFR2 LBD D2 <br /> | + | **[[3dar]], [[3caf]], [[3euu]] – hFGFR2 LBD D2 150-249<br /> |
**[[1wvz]] – hFGFR2 LBD D2 - NMR<br /> | **[[1wvz]] – hFGFR2 LBD D2 - NMR<br /> | ||
**[[4wv1]] – hFGFR2 LBD D2 + antibody<br /> | **[[4wv1]] – hFGFR2 LBD D2 + antibody<br /> | ||
| - | **[[4hwu]] – hFGFR2 LBD D1 <br /> | + | **[[6l4o]] – hFGFR2 LBD D2 (mutant) + API5<br /> |
| + | **[[4hwu]] – hFGFR2 LBD D1 45-127<br /> | ||
*''FGFR2 complex with FGF'' | *''FGFR2 complex with FGF'' | ||
| Line 71: | Line 73: | ||
**[[2lzl]] – hFGFR3 residues 357-399 – NMR<br /> | **[[2lzl]] – hFGFR3 residues 357-399 – NMR<br /> | ||
**[[4k33]] – hFGFR3 TKD (mutant)<br /> | **[[4k33]] – hFGFR3 TKD (mutant)<br /> | ||
| - | **[[6lvm]] – hFGFR3 TKD + inhibitor<br /> | + | **[[6lvm]], [[7dhl]] – hFGFR3 TKD + inhibitor<br /> |
**[[6pnx]] – hFGFR3 TKD (mutant) + ACP<br /> | **[[6pnx]] – hFGFR3 TKD (mutant) + ACP<br /> | ||
| Line 84: | Line 86: | ||
**[[4tye]], [[4tyg]], [[4tyi]], [[4tyj]] – hFGFR4 TKD <br /> | **[[4tye]], [[4tyg]], [[4tyi]], [[4tyj]] – hFGFR4 TKD <br /> | ||
**[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br /> | **[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br /> | ||
| - | **[[5jkg]], [[5nwz]], [[5nud]], [6nvg]], [[6nvh]], [[6nvi]], [[6nvj]], [[6nvk]], [[6v9c]] – hFGFR4 TKD + inhibitor<br /> | + | **[[5jkg]], [[5nwz]], [[5nud]], [6nvg]], [[6nvh]], [[6nvi]], [[6nvj]], [[6nvk]], [[6v9c]], [[7dtz]], [[7f3m]], [[7v29]], [[7vjl]], [[7wct]], [[7ybo]], [[7yc1]], [[7yc3]] – hFGFR4 TKD + inhibitor<br /> |
| - | **[[6jpj]], [[5xff]], [[5xfj]], [[6iuo]], [[6iup]], [[6jpe]], [[6jpj]] – hFGFR4 TKD (mutant) + inhibitor<br /> | + | **[[6yi8]] – hFGFR4 TKD + drug<br /> |
| + | **[[6jpj]], [[5xff]], [[5xfj]], [[6iuo]], [[6iup]], [[6jpe]], [[6jpj]], [[7wcx]], [[7ybp]], [[7ybx]] – hFGFR4 TKD (mutant) + inhibitor<br /> | ||
**[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br /> | **[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br /> | ||
| + | |||
| + | *''FGFR4 LBD'' | ||
| + | |||
**[[6j6y]] – hFGFR4 LBD D2 + antibody<br /> | **[[6j6y]] – hFGFR4 LBD D2 + antibody<br /> | ||
| + | **[[7n1j]], [[7tyd]] – hFGFR4 LBD D3 + binder<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
3D structures of fibroblast growth factor receptor
Updated on 05-March-2023
